Skip to main content

Afluria News (Page 3)

Universal Flu Vaccine Blocks Infection in Mice

THURSDAY, Aug. 22, 2024 – A universal flu vaccine that would protect against all influenza strains – and that people might not need to take every year – could be close at hand, researchers report....

CureVac’s Coronavirus Vaccine at the Center of a Fight for Control

CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...

Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.

Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...

Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older

CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Influenza Prophylaxis

Afluria patient information at Drugs.com